Condition: Corneal Scarring Fibrosis · Sponsor: Universidad Autonoma de Nuevo Leon
This is a prospective, randomized, double-blinded, controlled clinical trial designed to evaluate the efficacy and safety of topical losartan in improving visual acuity, contrast sensitivity and reducing corneal densitometry, corneal aberrations and corneal scarring severity in adult patients with corneal scars of different etiologies. Participants will be randomly assigned to receive either topical losartan 0.8 mg/mL or placebo eyedrops 6 times per day for six months.
This description comes directly from the study's public registry record.
Karim Mohamed-Noriega, Dr. med. · +52 8113404960 · karim.mohamednrg@uanl.edu.mx
Always discuss trial participation with your own doctor first.
| Ophthalmology Department | Monterrey, Nueo Leon, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07449000